Safety and Efficacy of Doses of LEO 43204 Once Daily for Two Consecutive Days on Full Balding Scalp in Subjects With Actinic Keratosis
Clinical trial NCT02100813 · COMPLETED
Trial details
- NCT number
- NCT02100813
- Sponsor
- LEO Pharma
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-05-01
- Primary completion
- 2015-03-01
- Enrollment
- 220
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.